Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
about
Recent advances in understanding hepatitis CDynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionStatus of hepatitis C virus vaccination: Recent updateImmune and non-immune responses to hepatitis C virus infectionHepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignImmune responses to HCV and other hepatitis virusesIdentification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoproteinBivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virusStructure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusDiscrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralizationStructure and specificity of an antibody targeting a proteolytically cleaved IgG hingeThe impact of hepatitis C virus entry on viral tropismProtein stability: a crystallographer's perspectiveFusion of Enveloped Viruses in Endosomes.Viral membrane fusion.Targeting host-derived glycans on enveloped viruses for antibody-based vaccine designProteomic approaches to analyzing hepatitis C virus biologyMorphology and Molecular Composition of Purified Bovine Viral Diarrhea Virus EnvelopeHepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous ClearanceUnexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.The missing pieces of the HCV entry puzzle.The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigsBroadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearanceA Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.Protective immunity against hepatitis C: many shades of gray.Immune control and failure in HCV infection--tipping the balance.Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Designing and Development of a DNA Vaccine Based On Structural Proteins of Hepatitis C VirusRecombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Will there be a vaccine to prevent HCV infection?Hepatitis C virus life cycle and lipid metabolismQuantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.
P2860
Q26766136-D1FDB860-CD68-4847-9E2F-FFF45E0B3461Q26772129-B611C2F7-1AE6-47B7-AE32-D86788637B1BQ26774612-11CE18A7-372B-4FDD-A41D-C8C79ACC89B4Q26782040-00CDC4BA-1212-452E-99A6-7B6DCB3158E4Q26799141-16404418-F702-4045-A947-541F71313370Q26801759-39EEAD4A-5D8B-4D1E-97D9-9DCA637A60FBQ26866955-596B121C-A519-4D9C-9B70-3F63D4A92548Q27333881-6E5A3B25-5BB4-4F28-B17A-669588F18BBCQ27469019-7CB3378A-9DA9-47AF-9C37-2F7FCD166E44Q27681839-1A4DEB77-F9A9-4F90-A1BE-7071E605A827Q27683156-F4FACA15-8DF3-4750-93CA-EACC618B8410Q27684579-61C220B8-10EA-4C5F-A9F1-7487FEBAEF3BQ27689552-04446E0E-A8E9-40A6-9850-FE41D1714D26Q27693297-AA7DC977-C23F-419A-B339-8C087C1F5F82Q28068775-D67CA5F2-AF29-48FD-8DEB-B63609B769DEQ28073406-8004663A-43B7-4057-B4D2-4F295C243BFFQ28080422-E0210A23-45F7-4AD9-96D0-5251EA264AD8Q28084672-B1E77CB7-A839-4066-91BB-E62E150CF681Q28085146-B01C6927-B632-49F3-82FA-036860ECB6F8Q28550514-EE1B4448-B395-4AA0-A992-45CE57F31DA1Q28552909-5A1F3AFA-1438-4605-A271-FE983658D9E8Q30364309-6E8F14C8-08F9-4C95-B870-A7DF60A59470Q30374314-812ADDE3-7604-4E7B-A67A-74FAAC3B2EE7Q30386551-B4710F50-B004-418E-9129-544AA02807D7Q33360674-7B8EA1B9-63E1-45FE-964D-374080837CEFQ33612608-45B87249-3FD6-40E5-9942-5101B8100414Q33631104-C3A78D94-5790-4A53-A56F-7AE734710A41Q33648339-76605564-FB08-4759-AA12-9C437F389B21Q33691856-DB261D9F-4010-4261-A030-DC0256438AB0Q33739145-D87C5CEA-8CFE-4485-A248-5B77330DE890Q33759224-BF2BE1CD-3575-4B0D-AE4B-7EBF7FD233F3Q34178628-FB4E3A67-BC9D-4BE3-9227-8C249CA17116Q34262175-9211D708-E05D-4A57-8EFC-E40FF568FF06Q34481429-F5ED4DB6-77A2-4E14-88E9-36B9DE856E20Q34543833-12F09F5B-C3FE-497D-99C1-651E3A42CE08Q34594986-E9289374-0B32-498B-87F6-5F0F2E972C36Q34781537-5781ABF1-A2AF-4127-B735-0F364ECD6C62Q34792436-16D11B86-0F75-42ED-8C35-E127C521B5E1Q35085189-ED0E3996-89D3-4BD3-B0DA-1B87476F0999Q35193285-FE0B4821-4C7E-4D12-A388-56C32E2DB4EB
P2860
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@ast
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@en
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@nl
type
label
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@ast
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@en
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@nl
prefLabel
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@ast
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@en
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@nl
P2093
P2860
P3181
P356
P1433
P1476
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
@en
P2093
Andrew B Ward
Dennis R Burton
Erick Giang
Kristin E Cogburn
Leopold Kong
Mansun Law
Rameshwar U Kadam
Robyn L Stanfield
Travis Nieusma
Xiaoping Dai
P2860
P304
P3181
P356
10.1126/SCIENCE.1243876
P407
P577
2013-11-29T00:00:00Z